AI-based Clinical Trials Solution Provider Market

AI-based Clinical Trials Solution Provider Market Size, Share, Growth Analysis, By Clinical Trial Phase(Phase-I, Phase-II), By Therapeutic Application(Oncology, Cardiovascular Diseases), By End-user(Pharmaceutical Companies, Academia), By Regional(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35G2102 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

AI-based Clinical Trials Solution Provider Market Insights

Market Overview:

The global AI-based clinical trials solutions market experienced significant growth in 2022, with a valuation of USD 1.6 billion. This upward trend is projected to continue over the next decade, with an estimated compound annual growth rate (CAGR) of 22.0% from 2023 to 2030. The increasing adoption of artificial intelligence technologies within the Health Care industry is a key driving factor behind this anticipated growth. AI-based clinical trials solutions offer numerous benefits, including improved efficiency, cost-effectiveness, and enhanced patient recruitment and retention rates. As pharmaceutical companies and research organizations recognize the potential of AI in streamlining clinical trial processes and generating valuable insights, the demand for AI-based clinical trials solutions is expected to soar in the coming years.

AI-based Clinical Trials Solution Provider Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Technology by segment aggregation, the contribution of the Health Care Technology in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for AI-based Clinical Trials Solution Provider was estimated to be valued at US$ XX Mn in 2021.

The AI-based Clinical Trials Solution Provider Market is estimated to grow at a CAGR of XX% by 2028.

The AI-based Clinical Trials Solution Provider Market is segmented on the basis of Clinical Trial Phase, Therapeutic Application, End-user, Regional.

Based on region, the AI-based Clinical Trials Solution Provider Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the AI-based Clinical Trials Solution Provider Market are Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi, Deep 6 AI, Innoplexus, Mendel.ai, Intelligencia, Median Technologies, Symphony AI, BioAge Labs, Inc., AiCure, LLC, CONSILX, DEEP LENS AI, Halo Health Systems, Pharmaseal, Ardigen, Trials.Ai, Koneksa Health, Euretos, BioSymetrics, Google- Verily, GNS Health Care, IBM Watson, Exscientia .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

AI-based Clinical Trials Solution Provider Market

Product ID: UCMIG35G2102

$5,300
BUY NOW GET FREE SAMPLE